Your browser doesn't support javascript.
loading
A novel peptide agonist of formyl-peptide receptor-like 1 (ALX) displays anti-inflammatory and cardioprotective effects.
Hecht, Iris; Rong, Jiang; Sampaio, André L F; Hermesh, Chen; Rutledge, Caleb; Shemesh, Ronen; Toporik, Amir; Beiman, Merav; Dassa, Liat; Niv, Hagit; Cojocaru, Gady; Zauberman, Arie; Rotman, Galit; Perretti, Mauro; Vinten-Johansen, Jakob; Cohen, Yossi.
Affiliation
  • Hecht I; Compugen Ltd., 72 Pinchas Rosen St., Tel Aviv, Israel 69512. iris.hecht@cgen.com
J Pharmacol Exp Ther ; 328(2): 426-34, 2009 Feb.
Article in En | MEDLINE | ID: mdl-19023040
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Receptors, Lipoxin / Receptors, Formyl Peptide / Inflammation / Anti-Inflammatory Agents / Myocardial Infarction Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: J Pharmacol Exp Ther Year: 2009 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Receptors, Lipoxin / Receptors, Formyl Peptide / Inflammation / Anti-Inflammatory Agents / Myocardial Infarction Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: J Pharmacol Exp Ther Year: 2009 Document type: Article Country of publication: